Brief: Basilea Reports FY 2022 Total Revenue Of CHF 147.8 Mln

Basilea Pharmaceutica AG, Allschwil

14/02/2023 06:27

Feb 14 (Reuters) - Basilea Pharmaceutica Ag  BSLN.S :
    * BASILEA REPORTS STRONG FINANCIAL RESULTS 2022 BASED ON
SUCCESSFUL IMPLEMENTATION OF NEW STRATEGY
    * TOTAL REVENUE IN THE FULL YEAR (FY) 2022 OF CHF 147.8
MILLION
(FY 2021: CHF 148.1 MILLION)
    * EXPECTS TO REMAIN PROFITABLE AND GENERATE POSITIVE CASH
FLOW
FROM OPERATING ACTIVITIES IN 2023
    * CRESEMBA & ZEVTERA RELATED REVENUE IS EXPECTED TO GROW BY
19% -
21% TO CHF 145 - 148 MILLION IN FY 2023

Source text for Eikon:  ID:nGNXKSNll 
Further company coverage:  BSLN.S 
 ((Reuters.Briefs@thomsonreuters.com;))